Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas C P Cross

Showing results (71-80 of 221) with videos related to

Pageof 23
Sort By:
Leukemia Research|July 24, 2010
JAK2(V617F) allele burden in polycythemia vera correlates with grade of myelofibrosis, but is not substantially affected by therapyRichard T Silver, Katherine Vandris, Y Lynn Wang, et al.
Haematologica|October 3, 2009
TFG, a target of chromosome translocations in lymphoma and soft tissue tumors, fuses to GPR128 in healthy individualsAndrew Chase, Thomas Ernst, Andreas Fiebig, et al.
Leukemia|July 8, 2020
Is cancer latency an outdated concept? Lessons from chronic myeloid leukemiaManuel Abecasis, Nicholas C P Cross, Manuel Brito, et al.
Haematologica|November 5, 2013
JAK2V617F allele burden is reduced by busulfan therapy: a new observation using an old drugEmil T Kuriakose, Stefani Gjoni, Y Lynn Wang, et al.
Acta Haematologica|November 23, 2007
Evaluation of JAK2 in B and T cell neoplasms: identification of JAK2(V617F) mutation of undetermined significance (JMUS) in the bone marrow of three individualsY Lynn Wang, Joong W Lee, Jonathan S Kui, et al.
Genes, Chromosomes & Cancer|November 14, 2008
Identification of a MYO18A-PDGFRB fusion gene in an eosinophilia-associated atypical myeloproliferative neoplasm with a t(5;17)(q33-34;q11.2)Christoph Walz, Claudia Haferlach, Annette Hänel, et al.
Haematologica|November 22, 2011
Decrease in JAK2 V617F allele burden is not a prerequisite to clinical response in patients with polycythemia veraEmil Kuriakose, Katherine Vandris, Y Lynn Wang, et al.
Cancer Cell|March 31, 2004
Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocationsSergei Roumiantsev, Daniela S Krause, Carola A Neumann, et al.
American Journal of Hematology|May 9, 2012
Fast-mode duplex qPCR for BCR-ABL1 molecular monitoring: innovation, automation, and harmonizationGareth Gerrard, Katherine Mudge, Pierre Foskett, et al.
Haematologica|August 10, 2012
Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangementsAndrew Chase, Catherine Bryant, Joannah Score, et al.
Pageof 23

Showing results (71-80 of 221) with videos related to

Sort By:
Pageof 23
Leukemia Research|July 24, 2010
JAK2(V617F) allele burden in polycythemia vera correlates with grade of myelofibrosis, but is not substantially affected by therapyRichard T Silver, Katherine Vandris, Y Lynn Wang, et al.
Haematologica|October 3, 2009
TFG, a target of chromosome translocations in lymphoma and soft tissue tumors, fuses to GPR128 in healthy individualsAndrew Chase, Thomas Ernst, Andreas Fiebig, et al.
Leukemia|July 8, 2020
Is cancer latency an outdated concept? Lessons from chronic myeloid leukemiaManuel Abecasis, Nicholas C P Cross, Manuel Brito, et al.
Haematologica|November 5, 2013
JAK2V617F allele burden is reduced by busulfan therapy: a new observation using an old drugEmil T Kuriakose, Stefani Gjoni, Y Lynn Wang, et al.
Acta Haematologica|November 23, 2007
Evaluation of JAK2 in B and T cell neoplasms: identification of JAK2(V617F) mutation of undetermined significance (JMUS) in the bone marrow of three individualsY Lynn Wang, Joong W Lee, Jonathan S Kui, et al.
Genes, Chromosomes & Cancer|November 14, 2008
Identification of a MYO18A-PDGFRB fusion gene in an eosinophilia-associated atypical myeloproliferative neoplasm with a t(5;17)(q33-34;q11.2)Christoph Walz, Claudia Haferlach, Annette Hänel, et al.
Haematologica|November 22, 2011
Decrease in JAK2 V617F allele burden is not a prerequisite to clinical response in patients with polycythemia veraEmil Kuriakose, Katherine Vandris, Y Lynn Wang, et al.
Cancer Cell|March 31, 2004
Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocationsSergei Roumiantsev, Daniela S Krause, Carola A Neumann, et al.
American Journal of Hematology|May 9, 2012
Fast-mode duplex qPCR for BCR-ABL1 molecular monitoring: innovation, automation, and harmonizationGareth Gerrard, Katherine Mudge, Pierre Foskett, et al.
Haematologica|August 10, 2012
Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangementsAndrew Chase, Catherine Bryant, Joannah Score, et al.
Pageof 23